Mobile Messaging Intervention to Present New HIV Prevention Options for Men Who Have Sex With Men (MSM)
| Status: | Recruiting |
|---|---|
| Conditions: | HIV / AIDS, HIV / AIDS, HIV / AIDS |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 9/13/2018 |
| Start Date: | January 24, 2018 |
| End Date: | September 2019 |
| Contact: | Ryan Zahn, MSPH |
| Email: | ryan.j.zahn@emory.edu |
| Phone: | 404-712-0123 |
Mobile Messaging Intervention to Present New HIV Prevention Options for MSM - Randomized Controlled Trial
The study will evaluate the use and effectiveness of mobile-messaging platforms as a public
health strategy for improving sexual health outcome measures among men who have sex with men
(MSM) by determining whether exposure to the message-delivery platform results in
improvements in participants' self-reported sexual health and prevention behaviors, beliefs
and attitudes. The study will enroll men into a randomized controlled trial. Participants
randomized to the messaging intervention will have access to a smartphone-based messaging
platform for three months while those assigned to the waitlist group will be offered access
to the messaging platform after all follow up is complete. Participants will complete surveys
at baseline, after the end of the 3 month intervention, and follow up surveys 6 and 9 months
after the baseline survey.
health strategy for improving sexual health outcome measures among men who have sex with men
(MSM) by determining whether exposure to the message-delivery platform results in
improvements in participants' self-reported sexual health and prevention behaviors, beliefs
and attitudes. The study will enroll men into a randomized controlled trial. Participants
randomized to the messaging intervention will have access to a smartphone-based messaging
platform for three months while those assigned to the waitlist group will be offered access
to the messaging platform after all follow up is complete. Participants will complete surveys
at baseline, after the end of the 3 month intervention, and follow up surveys 6 and 9 months
after the baseline survey.
This study aims to evaluate the use and effectiveness of a smartphone-based messaging
platform as a public health strategy for improving participants' self-reported sexual health
and prevention behaviors, beliefs and attitudes. The study will enroll 1,206 men into a
randomized controlled trial. They will be assigned to either the immediate intervention group
("intervention arm") or the waitlist-control group ("waitlist-control arm"). All participants
will take an assessment survey at baseline, and the intervention group will be oriented on
the installation and use of the messaging app upon randomization to that group. All men in
the randomized controlled trial will complete short follow-up surveys at 3-month intervals
during the 9-month follow-up period. When the intervention arm activities and assessments
have concluded, participants in the waitlist-control arm will then be given the option of
accessing to the intervention app and participation in intervention post-test activities.
platform as a public health strategy for improving participants' self-reported sexual health
and prevention behaviors, beliefs and attitudes. The study will enroll 1,206 men into a
randomized controlled trial. They will be assigned to either the immediate intervention group
("intervention arm") or the waitlist-control group ("waitlist-control arm"). All participants
will take an assessment survey at baseline, and the intervention group will be oriented on
the installation and use of the messaging app upon randomization to that group. All men in
the randomized controlled trial will complete short follow-up surveys at 3-month intervals
during the 9-month follow-up period. When the intervention arm activities and assessments
have concluded, participants in the waitlist-control arm will then be given the option of
accessing to the intervention app and participation in intervention post-test activities.
Inclusion Criteria:
- Assigned male at birth
- Current, self-reported gender identity as "Male"
- Aged 18 or over
- Self-reported ability to read and understand English-language
- Resides in the Atlanta, Georgia (GA), New York, New York (NY), or Detroit, Michigan
(MI) Metropolitan Statistical Area.
- Self-reported anal sex with a male partner in the past 12 months
- Owns and uses an Android or Apple (iOS) smartphone
- Is included in one of the following risk groups, by self-report:
- HIV seropositive
- HIV seronegative at "higher risk" (condomless anal sex and not taking PrEP as
prescribed in the past 3 months)
- HIV seronegative at "lower risk" (no condomless anal sex in the past 3 months, or
condomless and sex while taking PrEP as prescribed in the past 3 months)
Exclusion Criteria:
- Currently participating in another HIV prevention research study or program
- Participant's phone or device does not support HealthMindr application
- Tested positive for HIV for the first time in the past 6 months
- Has a plan to move out of the Atlanta, GA, New York, NY or Detroit, MI, Metropolitan
Statistical Area within in the next 9 months
We found this trial at
3
sites
Emory University Emory University, recognized internationally for its outstanding liberal artscolleges, graduate and professional schools,...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials